Dabaco strives to announce result of ASF vaccine research by December
The Dabaco Group Joint Stock Company has said it is striving to announce the result of its project on researching and producing a vaccine against African swine fever (ASF) by the end of this year.
A working delegation of the Ministry of Agriculture and Rural Development led by Deputy Minister Phung Duc Tien visited the group’s ASF vaccine research centre and laboratory on October 2.
Dabaco Chairman Nguyen Nhu So said that the vaccine is the outcome of transfer of biological products from the US Department of Agriculture’s research centre for exotic species diseases, the Nong nghiep Viet Nam (Vietnam Agriculture) newspaper reported.
The project, once successful, will be a breakthrough in producing vaccines, thus increasing the Vietnamese husbandry industry’s position and prestige, as there are no countries in the world succeeding in producing a vaccine against ASF.
Vietnam is targeting more than 90% of its communes and wards being free of African swine fever by 2022 and all by 2025, according to a national plan on African swine fever prevention for the 2020-2025 period.
The plan also targets 500 safe pig breeding facilities and 50 safe livestock chains, meeting domestic demand and for export.
